BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1273 related articles for article (PubMed ID: 19757340)

  • 1. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
    Auernhammer CJ; Göke B
    Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of neuroendocrine tumours of the gastrointestinal tract].
    Hansen CP; Langer S; Frevert S; Mortensen J; Kjaer A; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2942-5. PubMed ID: 21040671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroendocrine tumours of the GI tract--data from the German NET Registry].
    Begum N; Maasberg S; Plöckinger U; Anlauf M; Rinke A; Pöpperl G; Lehnert H; Izbicki JR; Krausch M; Vashist YK; Raffel A; Bürk CG; Hoffmann J; Goretzki P; Pape UF;
    Zentralbl Chir; 2014 Jun; 139(3):276-83. PubMed ID: 23042103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
    Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
    Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surgical management of neuroendocrine tumour hepatic metastases.
    Pathak S; Dash I; Taylor MR; Poston GJ
    Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.
    Pascher A; Klupp J; Neuhaus P
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):637-48. PubMed ID: 16183532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of liver metastases from gastrointestinal endocrine tumors.
    Boleslawski E; Dharancy S; Truant S; Pruvot FR
    Gastroenterol Clin Biol; 2010; 34(4-5):274-82. PubMed ID: 20347242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
    Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
    Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
    van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
    Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine tumours of the gastrointestinal tract].
    Plöckinger U; Wiedenmann B
    Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment strategies in advanced neuroendocrine tumours.
    Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G
    Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
    Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
    Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for primary and metastatic liver cancers.
    Hoti E; Adam R
    Transpl Int; 2008 Dec; 21(12):1107-17. PubMed ID: 18713148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
    Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
    Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.